Literature DB >> 15858143

Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology.

Baback Gharizadeh1, Maria Oggionni, Biying Zheng, Edit Akom, Nader Pourmand, Afshin Ahmadian, Keng-Ling Wallin, Pål Nyrén.   

Abstract

DNA sequencing is the gold standard method for accurate microbial and viral typing. However, DNA sequencing techniques have been facing limitations in typing of human papillomaviruses when the specimen harbors multiple genotypes and yields nonspecific amplification products, resulting in nonspecific and noninterpretable sequence data. To address these limitations we have developed a type-specific multiple sequencing primer DNA-sequencing method. This new strategy is suitable for sequencing and typing of samples harboring different genotypes (co-infections with multiple genotypes) and yielding nonspecific amplifications, thus eliminating the need for nested polymerase chain reaction (PCR), stringent PCR conditions, and cloning. The new approach has also proved useful for amplicons containing low PCR yield or subdominant types, avoiding reperforming of amplifications. We have applied the multiple sequencing primer method for genotyping of clinically relevant human papillomaviruses in a clinical test panel by using a combined pool of seven type-specific sequencing primers for HPV-6, -11, -16, -18, -31, -33, and -45. Furthermore, we introduced a sequence pattern recognition approach when there was a plurality of genotypes in the sample to facilitate typing of more than one target DNA in the sample. The multiple sequencing primer method has proved to be a multifaceted approach for typing of human papillomaviruses by DNA sequencing technologies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858143      PMCID: PMC1867525          DOI: 10.1016/S1525-1578(10)60546-6

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  17 in total

1.  Amplification of human genomic sequences by human papillomaviruses universal consensus primers.

Authors:  M E Fernández-Contreras; C Sarriá; S Nieto; P A Lazo
Journal:  J Virol Methods       Date:  2000-06       Impact factor: 2.014

Review 2.  Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications.

Authors:  K Milde-Langosch; S Riethdorf; T Löning
Journal:  Virchows Arch       Date:  2000-09       Impact factor: 4.064

3.  Typing of human papillomavirus by pyrosequencing.

Authors:  B Gharizadeh; M Kalantari; C A Garcia; B Johansson; P Nyrén
Journal:  Lab Invest       Date:  2001-05       Impact factor: 5.662

4.  Multiple-primer DNA sequencing method.

Authors:  Baback Gharizadeh; Mehran Ghaderi; Declan Donnelly; Bahram Amini; Keng-Ling Wallin; Pål Nyrén
Journal:  Electrophoresis       Date:  2003-04       Impact factor: 3.535

5.  Estimates of the worldwide frequency of sixteen major cancers in 1980.

Authors:  D M Parkin; E Läärä; C S Muir
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

Review 6.  Molecular detection and genotyping of human papillomavirus.

Authors:  L J van Doorn; B Kleter; W G Quint
Journal:  Expert Rev Mol Diagn       Date:  2001-11       Impact factor: 5.225

Review 7.  Diagnosing human papillomaviruses: recent advances.

Authors:  D Jenkins
Journal:  Curr Opin Infect Dis       Date:  2001-02       Impact factor: 4.915

8.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

9.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

10.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

View more
  21 in total

1.  Methodological improvements of pyrosequencing technology.

Authors:  Baback Gharizadeh; Michael Akhras; Nader Nourizad; Mehran Ghaderi; Kenji Yasuda; Pål Nyrén; Nader Pourmand
Journal:  J Biotechnol       Date:  2006-03-10       Impact factor: 3.307

2.  Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools.

Authors:  Emelyne Dejeux; Virginie Audard; Catherine Cavard; Ivo Glynne Gut; Benoit Terris; Jörg Tost
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

3.  The use of pyrosequencing for detection of hemagglutinin mutations associated with increased pathogenicity of H5N1 avian influenza viruses in mammals.

Authors:  Chenxi Wang; Yongning Zhang; Guoxia Bing; Xuxiao Zhang; Caixia Wang; Mingyang Wang; Yipeng Sun; Shaoqiang Wu; Xiangmei Lin; Juan Pu; Jinhua Liu; Honglei Sun
Journal:  J Vet Diagn Invest       Date:  2018-04-10       Impact factor: 1.279

4.  High levels of genetic variation within core Helicoverpa armigera nucleopolyhedrovirus genes.

Authors:  Vicky Lynne Baillie; Gustav Bouwer
Journal:  Virus Genes       Date:  2011-09-10       Impact factor: 2.332

5.  The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

Authors:  Christina S Kong; Balasubramanian Narasimhan; Hongbin Cao; Shirley Kwok; Julianna P Erickson; Albert Koong; Nader Pourmand; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-01       Impact factor: 7.038

6.  Pyrosequencing assay to rapidly detect clarithromycin resistance mutations in Canadian Helicobacter pylori isolates.

Authors:  R Slinger; L Yan; F Chan; K Forward; G Cooper-Lesins; L Best; D Haldane; S Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2009-09       Impact factor: 3.522

7.  Sentinel-base DNA genotyping using multiple sequencing primers for high-risk human papillomaviruses.

Authors:  Baback Gharizadeh; Biying Zheng; Michael Akhras; Mehran Ghaderi; Olufisayo Jejelowo; Björn Strander; Pål Nyrén; Keng-Ling Wallin; Nader Pourmand
Journal:  Mol Cell Probes       Date:  2006-03-03       Impact factor: 2.365

8.  Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?

Authors:  Björn Strander; Walter Ryd; Keng-Ling Wallin; Bengt Wärleby; Biying Zheng; Ian Milsom; Baback Gharizadeh; Nader Pourmand; Agneta Andersson-Ellström
Journal:  Eur J Cancer       Date:  2007-07-05       Impact factor: 9.162

9.  Human papillomavirus genotyping by multiplex pyrosequencing in cervical cancer patients from India.

Authors:  Cheryl M Travasso; Mona Anand; Mansi Samarth; Aditi Deshpande; Chandan Kumar-Sinha
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

10.  Validation of human papillomavirus genotyping by signature DNA sequence analysis.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Jessica S Vigliotti; Suri Pappu
Journal:  BMC Clin Pathol       Date:  2009-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.